Mitochondrial T9098C sequence change in the MTATP6 gene and development of severe mitochondrial disease after in utero antiretroviral prophylaxis.

Author: DolzhanskayaNatalia, MendezHermann, VelinovMilen

Paper Details 
Original Abstract of the Article :
Mitochondrial toxicity is a well-recognized adverse effect of nucleoside reverse transcriptase inhibitor therapy for human immunodeficiency virus (HIV) infection. Transient lactic acidosis is often observed in children born after in utero antiretroviral prophylaxis against mother-to-child transmissi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1592/phco.29.12.1491

データ提供:米国国立医学図書館(NLM)

A Genetic Crossroads: Mitochondrial Toxicity and Antiretroviral Treatment

Mitochondrial toxicity, a potential side effect of [antiretroviral treatment] for HIV, is a significant concern. This study investigated a case of severe mitochondrial disease in a child who received in utero antiretroviral prophylaxis. The researchers, like detectives unraveling a complex case, explored the potential link between a specific mitochondrial gene alteration and the development of mitochondrial disease. Their findings highlight the potential for genetic factors to contribute to the development of mitochondrial toxicity in the context of antiretroviral treatment.

A Warning Sign in the Desert of Antiretroviral Treatment

The study suggests that a specific mitochondrial gene alteration may increase the risk of developing severe mitochondrial disease in children exposed to antiretroviral treatment in utero. This finding emphasizes the need for continued vigilance in monitoring mitochondrial function in children receiving antiretroviral treatment. Like a lone traveler encountering a treacherous oasis, the researchers have uncovered a potential danger in the desert of antiretroviral treatment, highlighting the need for careful monitoring and proactive management.

A Call for Vigilance and Personalized Treatment

This case study highlights the importance of personalized medicine in the management of HIV infection. Carefully considering individual genetic factors and monitoring mitochondrial function could help minimize the risk of developing mitochondrial toxicity. It’s like navigating a complex desert landscape, requiring careful planning and attention to detail to avoid potential pitfalls.

Dr. Camel's Conclusion

This study serves as a cautionary tale, reminding us of the potential for genetic factors to contribute to the development of mitochondrial toxicity in the context of antiretroviral treatment. It emphasizes the need for continued research and vigilant monitoring to ensure the safety and effectiveness of antiretroviral therapies. It’s like a wise camel navigating a treacherous desert, always alert to potential dangers and adapting its path to ensure a safe and successful journey.

Date :
  1. Date Completed 2010-02-02
  2. Date Revised 2019-04-04
Further Info :

Pubmed ID

19947808

DOI: Digital Object Identifier

10.1592/phco.29.12.1491

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.